Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanton R Mehr

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Managed Care Interface|February 4, 2006
The evolutionary role of the pharmacy and therapeutics committee in technology assessmentStanton R Mehr
American Health & Drug Benefits|September 9, 2016
Will the PCSK9 Inhibitors Be Employers' "Line in the Sand"?Stanton R Mehr
The American Journal of Managed Care|January 11, 2013
The complexity of covering off-label use for a multitude of oncology regimensStanton R Mehr
The American Journal of Managed Care|January 26, 2015
Inhaled insulin's long journey to commercializationStanton R Mehr
The American Journal of Managed Care|January 26, 2015
Is Medicare ready for oncology clinical pathways?Stanton R Mehr
The American Journal of Managed Care|January 26, 2015
The continuing evolution of employer-based intervention in diabetes disease managementStanton R Mehr
The American Journal of Managed Care|September 27, 2012
How can we get better value in end-of-life care?Stanton R Mehr
The American Journal of Managed Care|May 31, 2012
Chronic myelogenous leukemiaJennifer Klemm, Stanton R Mehr
The American Journal of Managed Care|January 26, 2015
Managing the transition to adulthood with type 1 diabetes mellitus; an interview with Robert Kritzler, MDRobert Kritzler, Stanton R Mehr
The American Journal of Managed Care|May 31, 2012
Prostate cancerJennifer Klemm, Stanton R Mehr
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Managed Care Interface|February 4, 2006
The evolutionary role of the pharmacy and therapeutics committee in technology assessmentStanton R Mehr
American Health & Drug Benefits|September 9, 2016
Will the PCSK9 Inhibitors Be Employers' "Line in the Sand"?Stanton R Mehr
The American Journal of Managed Care|January 11, 2013
The complexity of covering off-label use for a multitude of oncology regimensStanton R Mehr
The American Journal of Managed Care|January 26, 2015
Inhaled insulin's long journey to commercializationStanton R Mehr
The American Journal of Managed Care|January 26, 2015
Is Medicare ready for oncology clinical pathways?Stanton R Mehr
The American Journal of Managed Care|January 26, 2015
The continuing evolution of employer-based intervention in diabetes disease managementStanton R Mehr
The American Journal of Managed Care|September 27, 2012
How can we get better value in end-of-life care?Stanton R Mehr
The American Journal of Managed Care|May 31, 2012
Chronic myelogenous leukemiaJennifer Klemm, Stanton R Mehr
The American Journal of Managed Care|January 26, 2015
Managing the transition to adulthood with type 1 diabetes mellitus; an interview with Robert Kritzler, MDRobert Kritzler, Stanton R Mehr
The American Journal of Managed Care|May 31, 2012
Prostate cancerJennifer Klemm, Stanton R Mehr
Pageof 4